D-24 | Reducing Use of Triple Therapy after Percutaneous Coronary Intervention: Results from a Hospital-wide Quality Improvement Initiative

Abstract

Randomized trials have shown that for patients on oral anticoagulants (OAC), a short course of dual antiplatelet therapy (DAPT) with OAC reduces post-percutaneous coronary intervention (PCI) bleeding without increasing ischemic events. However, adoption of this strategy has been variable. Here we evaluate the impact of an institutional initiative to reduce the use of triple therapy (TT, OAC + DAPT) post-PCI.